Combined flow cytometry and immunohistochemistry analyses for the assessment of nasopharyngeal carcinoma cell kinetics by in vivo bromodeoxyuridine infusion

Cytometry

Volumn 29, Issue 2, 1997, Pages 165-172

  Marchal, Sophie ^a   Marchal, Christian ^a   Parache, Robert Michel ^a   Benjaafar, Nouredine ^b   Odda, Mahiedine ^b   Leclerc, Anne ^a   Merlin, Jean Louis ^a   El Gueddarri, Brahini ^b   Bey, Pierre ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

^b MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

In vivo cell kinetics; Labelling index; Nasopharyngeal carcinoma; Potential doubling time

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CELL KINETICS; CELL PROLIFERATION; CLINICAL ARTICLE; FLOW CYTOMETRY; GROWTH RATE; HUMAN; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL;

ADULT; AGED; BROMODEOXYURIDINE; CARCINOMA; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; KINETICS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 0030771151     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19971001)29:2<165::AID-CYTO9>3.0.CO;2-C     Document Type: Article

References (32)

1. Awwad H: Unconventional fractionation studies and Tpot correlation. Sem Radiat Oncol 2:62-66, 1992.
2. Begg AC: The clinical status of Tpot as a predictor? or why no tempest in the Tpot! Int J Radiat Oncol Biol Phys 32:1539-1541, 1995.
3. Begg AC, Holland I: Cell kinetic analysis of mixed populations using three-colored fluorescence flow cytometry. Cytometry 12:445-454, 1991.
4. Begg AC, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Lefur R, Van den Bogaert W, Caspers R, Van Glabbeke M et al: The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumours: An interim report. Int J Radiat Oncol Biol Phys 19:1449-1453, 1990.
5. Begg AC, Hofland I, Van Glabekke M, Bartelink JC, Honot JC: Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC co-operative trial 22851. Sem Radiat Oncol 2:22-25, 1992.
6. Begg AC, McNally NJ, Shrieve DC, Kärcher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6:620-626, 1985.
7. Bennett MH, Wilson GD, Dische S, Saunders MI, Martindale CA, Robinson BM, O'Halloran AE, Leslie MD, Laing JHE: Tumor proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 65:870-878, 1992.
8. Bourhis J, Bosq J, Wilson GD, Bressac B, Talbot M, Leridan AM, Dendale R, Janin N, Armand JP, Luboinski B, Malaise EP, Wibault P, Eschwege F: Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer 57:458-462, 1994.
9. Cheng DS, Campbell BH, dowry LJ, Hopwood LE, Murray KJ, Toohill RJ, Hoffmann RG: DNA content in nasopharyngeal carcinoma. Am J Otolaryngol 11:393-397, 1990.
10. Cooke LD, Cooke TG, Forster G, Jones AS, Stell PM: Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumor factors and survival. Br J Cancer 69:717-720, 1994.
11. Corvo R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barras S, Margarine G, Bacigalupo A, Vitale V. Potential doubling time in head and neck tumors treated by primary radiotherapy: Preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol Biol Phys 27:1165-1172, 1993.
12. Costello F, Mason BR, Collins RJ, Kearsley JH: A clinical and flow cytometric analysis of patients with nasopharyngeal cancer. Cancer 66:1789-1795, 1990.
13. Dishe S: Radiotherapy - New fractionation scheme. Sem Oncol 21:3U4-310, 1994
14. Forster G, Cooke TG, Cooke LD, Stanton PD, Bowie G, Stell PM: Tumor growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 65:698-702, 1992.
15. Fowler JF: How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. Radiother Oncol 18:15-18, 1990.
16. Fowler JF: Potential for increasing the differential response between tumors and normal tissue: Can proliferation rate be used? Int J Radiat Oncol Biol Phys 12:641-645, 1985.
17. Fowler JF: Rapid repopulation in radiotherapy: Debate on mechanism, the phantom of tumor treatment - Continually rapid repopulation unmasked. Radiother Oncol 22:156-158, 1991.
18. Haustermans K, Vanuytsel K, Geboes K, Lerut T, Van Thillo J, Leysen J, Coosemans W, Van der Schueren E: In vivo cell kinetic measurements in human oesophageal cancer: what can be learned from multiple biopsies. Eur J Cancer 30A:1787-1791, 1994.
19. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA: Convention on nomenclature for DNA cytometry Cancer Gene Cytogenet 134:181-183, 1984.
20. Konorza G, Sesterhenn K, Krueger GRF, Ablashi DV: Distribution of T-and B-cells and of immunoglobulin-producing cells in tumor tissue of patients with nasopharyngeal carcinoma. J Cancer Res Clin Oncol 93:195-204, 1979.
21. Lee AWM, Chan DKK, Fowler JF, Poon YF, Foo W, Law SCK, O SK, Tung SY, Chappell R: Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiother Oncol 36:24-31, 1995.
22. Magaud JP, Sargent I, Clarke PJ, French M, Rimokh R, Mason DY: Double immunocytochemical labelling of cell and tissue samples with monoclonal anti-bromodeoxyuridine. J Histochem Cytochem 31:1517-1527, 1989.
23. Nylander K, Anneroth G, Gustafsson H, Roos G, Stenling R, Zackrisson B: Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications. Acta Oncol 1:23-28, 1994.
24. Peters LJ, Ang KK: The role of alterated fractionation in head and neck cancers. Sem Radiat Oncol 2:180-194, 1992.
25. Peters LJ, Ang KK, Thames HD: Accelerated fractionation in the treatment of head and neck cancer: a critical comparison of different strategies. Acta Oncol 21:185-194, 1988.
26. Riccardi A, Danova M, Wilson G, Ucci G, Dörmer P, Mazzini G, Brugnatelli S, Girino M, McNally NJ, Ascari E: Cell kinetics in human malignancies studies with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res 48:6238-6245, 1988.
27. Rovchowdhury DF, Tseng A, Fu KK, Windberg V, Weidner N: New prognostic factors in nasopharyngeal carcinoma: Tumor angiogenesis and C-erbB2 expression. Cancer 77:1419-1426, 1996.
28. Schultz-Hector S, Begg AC, Hofland I, Kummermehr J, Sund M: Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry. Br J Cancer 68:1097-1103, 1993.
29. Trott KR: Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys 19:1071-1075, 1989.
30. Wilson GD: Assessment of human tumour proliferation using bromodeoxyuridine-current status. Acta Oncol 30:903-910, 1991.
31. Withers HR, Taylor JM, Maciejesky B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-146, 1988.
32. Zheng X, Hu L, Chen F, Christensson B: Expression of KI67 antigen, epidermal growth factor receptor and Epstein-Barr-Virus encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur J Cancer Oral Oncol 308:290-295, 1994.